Abstract

Taking place September 15 in Boston at BioPharm Americaa„¢, Digital Medicine Connect will address the need for evidence-driven validation of digital medicine products, unique business models emerging within the space, regulatory considerations and differing roles of pharma, researchers, tech developers and other stakeholders.